{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:35:51Z","timestamp":1790516151801,"version":"4.1.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Uniwersytet Medyczny w Lodzi","doi-asserted-by":"publisher","award":["grants from Medical University of Lodz (No 503\/1-152-01\/503-11-002 and 503\/1-093-01\/503-11-001-19-00) Poland."],"award-info":[{"award-number":["grants from Medical University of Lodz (No 503\/1-152-01\/503-11-002 and 503\/1-093-01\/503-11-001-19-00) Poland."]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Skin lesions have been reported in about 10\u201312% of hairy cell leukemia (HCL) patients. Most are etiologically related to autoimmune or infectious processes, although secondary cutaneous neoplasms and drug-induced lesions are also reported. However, leukemia cutis with the direct infiltration of the skin by leukemic cells is extremely rare in HCL patients. This paper reviews the epidemiology, pathogenesis, clinical symptoms, diagnosis, and approach to treating skin lesions in HCL. A literature review of the MEDLINE database for articles in English concerning hairy cell leukemia, skin lesions, leukemia cutis, adverse events, infectious, cutaneous, drug reactions, neutrophilic dermatoses, secondary neoplasms, and vasculitis was conducted via PubMed. Publications from January 1980 to September 2020 were scrutinized. Additional relevant publications were obtained by reviewing the references from the chosen articles.<\/jats:p>","DOI":"10.1007\/s00277-020-04349-z","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T14:06:13Z","timestamp":1605881173000},"page":"615-625","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Skin changes in hairy cell leukemia"],"prefix":"10.1007","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4633-9160","authenticated-orcid":false,"given":"Ewa","family":"Robak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9319-9570","authenticated-orcid":false,"given":"Dorota","family":"Jesionek-Kupnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3411-6357","authenticated-orcid":false,"given":"Tadeusz","family":"Robak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"issue":"5","key":"4349_CR1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood-2016-01-689422","volume":"129","author":"MR Grever","year":"2017","unstructured":"Grever MR, Abdel-Wahab O, Andritsos LA, Banerji V, Barrientos J, Blachly JS, Call TG, Catovsky D, Dearden C, Demeter J, Else M, Forconi F, Gozzetti A, Ho AD, Johnston JB, Jones J, Juliusson G, Kraut E, Kreitman RJ, Larratt L, Lauria F, Lozanski G, Montserrat E, Parikh SA, Park JH, Polliack A, Quest GR, Rai KR, Ravandi F, Robak T, Saven A, Seymour JF, Tadmor T, Tallman MS, Tam C, Tiacci E, Troussard X, Zent CS, Zenz T, Zinzani PL, Falini B (2017) Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood 129(5):553\u2013560","journal-title":"Blood"},{"issue":"Suppl 5","key":"4349_CR2","doi-asserted-by":"crossref","first-page":"v100","DOI":"10.1093\/annonc\/mdv200","volume":"26","author":"T Robak","year":"2015","unstructured":"Robak T, Matutes E, Catovsky D, Zinzani PL, Buske C, ESMO Guidelines Committee (2015) Hairy cell leukaemia: ESMO Clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(Suppl 5):v100\u2013v107","journal-title":"Ann Oncol"},{"issue":"6","key":"4349_CR3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3322\/caac.21357","volume":"66","author":"LR Teras","year":"2016","unstructured":"Teras LR, Desantis DE, Cerhan JR, Morton LM, Jemal A, Flowers CR (2016) 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin 66(6):443\u2013459","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"4349_CR4","first-page":"3605","volume":"50","author":"L Bernstein","year":"1990","unstructured":"Bernstein L, Newton P, Ross RK (1990) Epidemiology of hairy cell leukemia in Los Angeles County. Cancer Res 50(12):3605\u20133609","journal-title":"Cancer Res"},{"issue":"3","key":"4349_CR5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.thj.6200167","volume":"3","author":"SY Kristinsson","year":"2002","unstructured":"Kristinsson SY, Vidarsson B, Agnarsson BA, Haraldsdottir V, Olafsson O, Johannesson GM, Eyjolfsson GI, Bjornsdottir J, Onundarson PT, Reykdal S (2002) Epidemiology of hairy cell leukemia in Iceland. Hematol J 3(3):145\u2013147","journal-title":"Hematol J"},{"issue":"4","key":"4349_CR6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1468-0734.2002.00304.x","volume":"6","author":"A Polliack","year":"2002","unstructured":"Polliack A (2002) Hairy cell leukemia: biology, clinical diagnosis, unusual manifestations and associated disorders. Rev Clin Exp Hematol 6(4):366\u2013388","journal-title":"Rev Clin Exp Hematol"},{"issue":"Suppl 2","key":"4349_CR7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/10428194.2011.565395","volume":"52","author":"T Tadmor","year":"2011","unstructured":"Tadmor T, Polliack A (2011) Unusual clinical manifestations, rare sites of involvement, and the association of other disorders with hairy cell leukemia. Leuk Lymphoma 52(Suppl 2):57\u201361","journal-title":"Leuk Lymphoma"},{"key":"4349_CR8","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/ejh.13505","volume":"105","author":"P Robak","year":"2020","unstructured":"Robak P, Jesionek-Kupnicka D, Kupnicki P, Polliack A, Robak T (2020) Bone lesions in hairy cell leukemia: diagnosis and treatment. Eur J Haematol 105:682\u2013691. https:\/\/doi.org\/10.1111\/ejh.13505","journal-title":"Eur J Haematol"},{"issue":"16","key":"4349_CR9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM199004193221605","volume":"322","author":"LD Piro","year":"1990","unstructured":"Piro LD, Carrera CJ, Carson DA, Beutler E (1990) Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 322(16):1117\u20131721","journal-title":"N Engl J Med"},{"issue":"3","key":"4349_CR10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/bjh.12490","volume":"163","author":"R Chandran","year":"2013","unstructured":"Chandran R, Gardiner SK, Smith SD, Spurgeon SE (2013) Improved survival in hairy cell leukaemia over three decades: a SEER database analysis of prognostic factors. Br J Haematol 163(3):407\u2013409","journal-title":"Br J Haematol"},{"issue":"6","key":"4349_CR11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2141.2009.07668.x","volume":"145","author":"M Else","year":"2009","unstructured":"Else M, Dearden CE, Matutes E, Garcia-Talavera J, Rohatiner AZ, Johnson SA, O'Connor NT, Haynes A, Osuji N, Forconi F, Lauria F, Catovsky D (2009) Long-term follow-up of 233 patients with hairy cell leukaemia treated initially with pentostatin or cladribine at a median of 16 years. Br J Haematol 145(6):733\u2013740","journal-title":"Br J Haematol"},{"issue":"10","key":"4349_CR12","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1182\/blood-2009-10-251645","volume":"115","author":"DS Sigal","year":"2010","unstructured":"Sigal DS, Sharpe R, Burian C, Saven A (2010) Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine. Blood 115(10):1893\u20131896","journal-title":"Blood"},{"issue":"2","key":"4349_CR13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2141.1992.tb08202.x","volume":"81","author":"MR Baer","year":"1992","unstructured":"Baer MR, Ozer H, Foon KA (1992) Interferon-alpha therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia. Br J Haematol 81(2):167\u2013169","journal-title":"Br J Haematol"},{"issue":"Suppl 2","key":"4349_CR14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/10428194.2011.573033","volume":"52","author":"TM Habermann","year":"2011","unstructured":"Habermann TM, Rai K (2011) Historical treatments of in hairy cell leukemia, splenectomy and interferon: past and current uses. Leuk Lymphoma 52(Suppl 2):18\u201320","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"4349_CR15","first-page":"929","volume":"9","author":"JF Seymour","year":"1995","unstructured":"Seymour JF, Estey EH, Keating MJ, Kurzrock R (1995) (1995) Response to interferon-\u03b1 in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine. Leukemia 9(5):929\u2013932","journal-title":"Leukemia"},{"issue":"1","key":"4349_CR16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00277-014-2175-0","volume":"94","author":"M Leclerc","year":"2015","unstructured":"Leclerc M, Suarez F, No\u00ebl MP, Vekhoff A, Troussard X, Claisse JF, Thieblemont C, Maloisel F, Beguin Y, Tamburini J, Barbe C, Delmer A (2015) Rituximab therapy for hairy cell leukemia: a retrospective study of 41 cases. Ann Hematol 94(1):89\u201395","journal-title":"Ann Hematol"},{"issue":"12","key":"4349_CR17","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1182\/blood-2003-02-0630","volume":"102","author":"DA Thomas","year":"2003","unstructured":"Thomas DA, O\u2019Brien S, Bueso-Ramos C, Faderl S, Keating MJ, Giles FJ, Cortes J, Kantarjian HM (2003) Rituximab in relapsed or refractory hairy cell leukemia. Blood 102(12):3906\u20133911","journal-title":"Blood"},{"issue":"3","key":"4349_CR18","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1182\/blood-2003-01-0014","volume":"102","author":"J Nieva","year":"2003","unstructured":"Nieva J, Bethel K, Saven A (2003) Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia. Blood 102(3):810\u2013813","journal-title":"Blood"},{"issue":"5","key":"4349_CR19","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/bjh.14129","volume":"174","author":"D Chihara","year":"2016","unstructured":"Chihara D, Kantarjian H, O'Brien S, Jorgensen J, Pierce S, Ferrajoli A, Poku R, Jain P, Thompson P, Brandt M, Luthra R, Burger J, Keating M, Ravandi F (2016) Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial. Br J Haematol 174(5):760\u2013766","journal-title":"Br J Haematol"},{"issue":"11","key":"4349_CR20","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1517\/13543784.2015.1081895","volume":"24","author":"T Robak","year":"2015","unstructured":"Robak T, Wolska A, Robak P (2015) Potential breakthroughs with investigational drugs for hairy cell leukemia. Expert Opin Investig Drugs 24(11):1419\u20131431","journal-title":"Expert Opin Investig Drugs"},{"issue":"8","key":"4349_CR21","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1038\/s41375-018-0210-1","volume":"32","author":"RJ Kreitman","year":"2018","unstructured":"Kreitman RJ, Dearden C, Zinzani PL, Delgado J, Karlin L, Robak T, Gladstone DE, le Coutre P, Dietrich S, Gotic M, Larratt L, Offner F, Schiller G, Swords R, Bacon L, Bocchia M, Bouabdallah K, Breems DA, Cortelezzi A, Dinner S, Doubek M, Gjertsen BT, Gobbi M, Hellmann A, Lepretre S, Maloisel F, Ravandi F, Rousselot P, Rummel M, Siddiqi T, Tadmor T, Troussard X, Yi CA, Saglio G, Roboz GJ, Balic K, Standifer N, He P, Marshall S, Wilson W, Pastan I, Yao NS, Giles F (2018) Moxetumomab pasudotox in relapsed\/ refractory hairy cell leukemia. Leukemia 32(8):1768\u20131777","journal-title":"Leukemia"},{"issue":"18","key":"4349_CR22","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJMoa1506583","volume":"373","author":"E Tiacci","year":"2015","unstructured":"Tiacci E, Park JH, De Carolis L, Chung SS, Broccoli A, Scott S, Zaja F, Devlin S, Pulsoni A, Chung YR, Cimminiello M, Kim E, Rossi D, Stone RM, Motta G, Saven A, Varettoni M, Altman JK, Anastasia A, Grever MR, Ambrosetti A, Rai KR, Fraticelli V, Lacouture ME, Carella AM, Levine RL, Leoni P, Rambaldi A, Falzetti F, Ascani S, Capponi M, Martelli MP, Park CY, Pileri SA, Rosen N, Fo\u00e0 R, Berger MF, Zinzani PL, Abdel-Wahab O, Falini B, Tallman MS (2015) Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia. N Engl J Med 373(18):1733\u20131747","journal-title":"N Engl J Med"},{"issue":"12","key":"4349_CR23","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/s00277-014-2104-2","volume":"93","author":"V Vergote","year":"2014","unstructured":"Vergote V, Dierickx D, Janssens A, Verhoef G, Tousseyn T, Vandenberghe P, Wolter P, Delforge M (2014) Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib. Ann Hematol 93(12):2087\u20132089","journal-title":"Ann Hematol"},{"issue":"8","key":"4349_CR24","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1080\/07357900801965034","volume":"26","author":"T Cannon","year":"2008","unstructured":"Cannon T, Mobarek D, Wegge J, Tabbara IA (2008) Hairy cell leukemia: current concepts. Cancer Investig 26(8):860\u2013865","journal-title":"Cancer Investig"},{"issue":"6","key":"4349_CR25","first-page":"541","volume":"35","author":"F Carsuzaa","year":"1994","unstructured":"Carsuzaa F, Pierre C, Jaubert D, Viala JJ (1994) Cutaneous findings in hairy cell leukemia. Review of 84 cases. Nouv Rev Fr Hematol 35(6):541\u2013543","journal-title":"Nouv Rev Fr Hematol"},{"issue":"2","key":"4349_CR26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s12032-009-9246-4","volume":"27","author":"N Colovi\u0107","year":"2010","unstructured":"Colovi\u0107 N, Perunici\u0107 M, Jurisi\u0107 V, Colovi\u0107 M (2010) Specific skin lesions in hairy cell leukemia at presentation: case report and review of literature. Med Oncol 27(2):559\u2013561","journal-title":"Med Oncol"},{"issue":"1","key":"4349_CR27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1309\/WYACYWF6NGM3WBRT","volume":"129","author":"JH Cho-Vega","year":"2008","unstructured":"Cho-Vega JH, Medeiros LJ, Prieto VG, Vega F (2008) Leukemia cutis. Am J Clin Pathol 129(1):130\u2013142","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"4349_CR28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/10428190601137336","volume":"48","author":"E Robak","year":"2007","unstructured":"Robak E, Robak T (2007) Skin lesions in chronic lymphocytic leukemia. Leuk Lymphoma 48(5):855\u2013865","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"4349_CR29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/ajcp\/90.4.459","volume":"90","author":"E Arai","year":"1988","unstructured":"Arai E, Ikeda S, Itoh S, Katayama I (1988) Specific skin lesions as the presenting symptom of hairy cell leukemia. Am J Clin Pathol 90(4):459\u2013464","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"4349_CR30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2230.1991.tb00349.x","volume":"16","author":"D Bilsland","year":"1991","unstructured":"Bilsland D, Shahriari S, Douglas WS, Chaudhuri AK, Todd WT (1991) Transient leukaemia cutis in hairy-cell leukaemia. Clin Exp Dermatol 16(3):207\u2013209","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"4349_CR31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archderm.1983.01650280050015","volume":"119","author":"DM Lawrence","year":"1983","unstructured":"Lawrence DM, Sun NCJ, Mena R, Moss R (1983) Cutaneous lesions in hairy cell leukemia. Case report and review of the literature. Arch Dermatol 119(4):322\u2013325","journal-title":"Arch Dermatol"},{"issue":"3\u20134","key":"4349_CR32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/10428199409056295","volume":"13","author":"A Fressoldati","year":"1994","unstructured":"Fressoldati A, Lamparelli T, Federico M, Annino L, Capnist G, Pagnucco G, Dini E, Resegotti L, Damasio EE, Silingardi V (1994) Hairy cell leukemia: a clinical review based on 725 cases of the Italian Cooperative Group (ICGHCL). Leuk Lymphoma 13(3\u20134):307\u2013316","journal-title":"Leuk Lymphoma"},{"issue":"5 Pt 1","key":"4349_CR33","first-page":"788","volume":"11","author":"MC Finan","year":"1998","unstructured":"Finan MC, Su WP, Li CY (1998) Cutaneous findings in hairy cell leukemia. J Am Acad Dermatol 11(5 Pt 1):788\u2013797","journal-title":"J Am Acad Dermatol"},{"key":"4349_CR34","unstructured":"Parsi M, Go MS, Ahmed A (2020) Cancer, leukemia cutis. 2020 Aug 8. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2020 Jan."},{"issue":"2","key":"4349_CR35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.transci.2012.01.011","volume":"46","author":"U Ergene","year":"2012","unstructured":"Ergene U, Ozbalc\u0131 D, I\u015fisa\u011f A (2012) Hairy cell leukemia and cutaneous involvement. Transfus Apher Sci 46(2):231\u2013232","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"4349_CR36","first-page":"311","volume":"26","author":"P Fino","year":"2012","unstructured":"Fino P, Fioramonti P, Onesti MG, Passaretti D, Scuderi N (2012) Skin metastasis in patient with hairy cell leukemia: case report and review of literature. In Vivo 26(2):311\u2013314","journal-title":"In Vivo"},{"issue":"suppl 2","key":"4349_CR37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/10428194.2011.565093","volume":"52","author":"CE Dearden","year":"2011","unstructured":"Dearden CE, Else M, Catovsky D (2011) Long-term results for pentostatin and cladribine treatment of hairy cell leukemia. Leuk Lymphoma 52(suppl 2):21\u201324","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"4349_CR38","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1182\/blood.V92.4.1160","volume":"92","author":"WY Au","year":"1998","unstructured":"Au WY, Klasa RJ, Gallagher R, Le N, Gascoyne RD, Connors JM (1998) Second malignancies in patients with hairy cell leukemia in British Columbia: a 20-year experience. Blood 92(4):1160\u20131164","journal-title":"Blood"},{"key":"4349_CR39","first-page":"1918","volume":"6","author":"A Saven","year":"1992","unstructured":"Saven A, Burian C, Koziol JA, Piro LD (1992) Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood 6:1918\u20131926","journal-title":"Blood"},{"issue":"5","key":"4349_CR40","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1200\/JCO.1997.15.5.1803","volume":"15","author":"R Kurzrock","year":"1997","unstructured":"Kurzrock R, Strom SS, Estey E, O\u2019Brien S, Keating MJ, Jiang H, Adams T, Talpaz M (1997) Second cancer risk in hairy cell leukemia: analysis of 350 patients. J Clin Oncol 15(5):1803\u20131810","journal-title":"J Clin Oncol"},{"issue":"3","key":"4349_CR41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jnci\/djk030","volume":"99","author":"M Hisada","year":"2007","unstructured":"Hisada M, Chen BE, Jaffe ES, Travis LB (2007) Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study. J Natl Cancer Inst 99(3):215\u2013222","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"4349_CR42","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/bloodadvances.2020002160","volume":"4","author":"R Benz","year":"2020","unstructured":"Benz R, Arn K, Andres M, Pabst T, Baumann M, Novak U, Hitz F, Hess U, Zenhaeusern R, Chalandon Y, Mey U, Blum S, Rauch D, O\u2019Meara Stern A, Cantoni N, Bargetzi M, Bianchi-Papina E, Rossi D, Passweg J, Lohri A, Berardi S, Li Q, Feller A, Stussi G (2020) Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial. Blood Adv 4(15):3699\u20133707","journal-title":"Blood Adv"},{"key":"4349_CR43","doi-asserted-by":"crossref","first-page":"106165","DOI":"10.1016\/j.leukres.2019.06.001","volume":"83","author":"WF da Silva","year":"2019","unstructured":"da Silva WF, Neto AC, da Rosa LI, de Siqueira IA, Amarante GD, Velloso EDRP, Rego EM, Rocha V, Buccheri V (2019) Outcomes and second neoplasms in hairy cell leukemia: a retrospective cohort. Leuk Res 83:106165","journal-title":"Leuk Res"},{"issue":"1","key":"4349_CR44","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1046\/j.1365-2133.1999.02626.x","volume":"140","author":"MP Sch\u00f6n","year":"1999","unstructured":"Sch\u00f6n MP, Reifenberger J, Von Schmiedeberg S, Megahed M, Lang K, Gattermann N, Meckenstock G, Goerz G, Ruzicka T (1999) Multiple basal cell carcinomas associated with hairy cell leukaemia. Br J Dermatol 140(1):150\u2013153","journal-title":"Br J Dermatol"},{"issue":"1","key":"4349_CR45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/bjh.13528","volume":"171","author":"JM Watts","year":"2015","unstructured":"Watts JM, Kishtagari A, Hsu M, Lacouture ME, Postow MA, Park JH, Stein EM, Teruya-Feldstein J, Abdel-Wahab O, Devlin SM, Tallman MS (2015) Melanoma and non-melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer Center. Br J Haematol 171(1):84\u201390","journal-title":"Br J Haematol"},{"key":"4349_CR46","doi-asserted-by":"crossref","unstructured":"Su F, Viros A, Milagre C, Trunzer K, Bollag G, Spleiss O, Reis-Filho JS, Kong X, Koya RC, Flaherty KT, Chapman PB, Kim MJ, Hayward R, Martin M, Yang H, Wang Q, Hilton H, Hang JS, Noe J, Lambros M, Geyer F, Dhomen N, Niculescu-Duvaz I, Zambon A, Niculescu-Duvaz D, Preece N, Robert L, Otte NJ, Mok S, Kee D, Ma Y, Zhang C, Habets G, Burton EA, Wong B, Nguyen H, Kockx M, Andries L, Lestini B, Nolop KB, Lee RJ, Joe AK, Troy JL, Gonzalez R, Hutson TE, Puzanov I, Chmielowski B, Springer CJ, McArthur GA, Sosman JA, Lo RS, Ribas A, Marais R RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors. N Engl J Med 366(3):207\u2013215","DOI":"10.1056\/NEJMoa1105358"},{"issue":"3","key":"4349_CR47","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1634\/theoncologist.2012-0333","volume":"18","author":"ME Lacouture","year":"2013","unstructured":"Lacouture ME, Duvic M, Hauschild A, Prieto VG, Robert C, Schadendorf D, Kim CC, McCormack CJ, Myskowski PL, Spleiss O, Trunzer K, Su F, Nelson B, Nolop KB, Grippo JF, Lee RJ, Klimek MJ, Troy JL, Joe AK (2013) Analysis of dermatologic events in vemurafenib-treated patients with melanoma. Oncologist 18(3):314\u2013322","journal-title":"Oncologist"},{"issue":"19","key":"4349_CR48","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1200\/JCO.2011.41.1660","volume":"30","author":"L Zimmer","year":"2012","unstructured":"Zimmer L, Hillen U, Livingstone E, Lacouture ME, Busam K, Carvajal RD, Egberts F, Hauschild A, Kashani-Sabet M, Goldinger SM, Dummer R, Long GV, McArthur G, Scherag A, Sucker A, Schadendorf D (2012) Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition. J Clin Oncol 30(19):2375\u20132383","journal-title":"J Clin Oncol"},{"issue":"2","key":"4349_CR49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/CCO.0b013e3283436e8c","volume":"23","author":"C Robert","year":"2011","unstructured":"Robert C, Arnault JP, Mateus C (2011) RAF inhibition and induction of cutaneous squamous cell carcinoma. Curr Opin Oncol 23(2):177\u2013182","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"4349_CR50","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1200\/JCO.2011.36.7680","volume":"30","author":"PA Oberholzer","year":"2012","unstructured":"Oberholzer PA, Kee D, Dziunycz P, Sucker A, Kamsukom N, Jones R, Roden C, Chalk CJ, Ardlie K, Palescandolo E, Piris A, MacConaill LE, Robert C, Hofbauer GF, McArthur GA, Schadendorf D, Garraway LA (2012) RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors. J Clin Oncol 30(3):316\u2013321","journal-title":"J Clin Oncol"},{"issue":"18","key":"4349_CR51","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","volume":"367","author":"KT Flaherty","year":"2012","unstructured":"Flaherty KT, Infante JR, Daud A, Gonzalez R, Kefford RF, Sosman J, Hamid O, Schuchter L, Cebon J, Ibrahim N, Kudchadkar R, Burris HA 3rd, Falchook G, Algazi A, Lewis K, Long GV, Puzanov I, Lebowitz P, Singh A, Little S, Sun P, Allred A, Ouellet D, Kim KB, Patel K, Weber J (2012) Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N Engl J Med 367(18):1694\u20131703","journal-title":"N Engl J Med"},{"key":"4349_CR52","doi-asserted-by":"crossref","unstructured":"Kreitman RJ, Moreau P, Hutchings M, Gazzah A, Blayn JY, Wainberg ZA, Stein A, Dietrich S, de Jonge MJA, Willenbacher W, De Greve J, Arons E, Ravandi F, Rangwala F, Burgess P, Mookerjee B, Subbiah V (2018) Treatment with combination of dabrafenib and trametinib in patients with recurrent\/refractory BRAF V600E-mutated hairy cell leukemia (HCL). Blood 132 Abstract 391","DOI":"10.1182\/blood-2018-99-113135"},{"issue":"2","key":"4349_CR53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41375-018-0270-2","volume":"33","author":"R Caeser","year":"2019","unstructured":"Caeser R, Collord G, Yao WQ, Chen Z, Vassiliou GS, Beer PA, Du MQ, Scott MA, Follows GA, Hodson DJ (2019) Targeting MEK in vemurafenib resistant hairy cell leukemia. Leukemia. 33(2):541\u2013545","journal-title":"Leukemia."},{"issue":"5","key":"4349_CR54","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1080\/10428194.2018.1519809","volume":"60","author":"MS Bhangoo","year":"2019","unstructured":"Bhangoo MS, Saven A (2019) Secondary malignancies after treatment with single-agent vemurafenib in two patients with refractory hairy cell leukemia. Leuk Lymphoma 60(5):1331\u20131333","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"4349_CR55","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/bjh.15777","volume":"185","author":"G Zheng","year":"2019","unstructured":"Zheng G, Chattopadhyay S, Sud A, Sundquist K, Sundquist J, F\u00f6rsti A, Houlston R, Hemminki A, Hemminki K (2019) Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia. Br J Haematol 185(2):232\u2013239","journal-title":"Br J Haematol"},{"issue":"3","key":"4349_CR56","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/1096-8652(200007)64:3<197::AID-AJH10>3.0.CO;2-F","volume":"64","author":"R Paolini","year":"2000","unstructured":"Paolini R, Poletti A, Ramazzina E, Menin C, Santacatterina M, Montagna M, Bonaldi L, Del Mistro A, Zamboni S, D\u2019Andrea E (2000) Co-existence of cutaneous T-cell lymphoma and B hairy cell leukemia. Am J Hematol 64(3):197\u2013202","journal-title":"Am J Hematol"},{"issue":"7","key":"4349_CR57","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00277-007-0276-8","volume":"86","author":"C Hallermann","year":"2007","unstructured":"Hallermann C, Kaune MK, Tiemann M, Kunze E, Griesinger F, Mitteldorf C, Bertsch HP, Neumann C (2007) High frequency of primary cutaneous lymphomas associated with lymphoproliferative disorders of different lineage. Ann Hematol 86(7):509\u2013515","journal-title":"Ann Hematol"},{"issue":"1","key":"4349_CR58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000456650","volume":"9","author":"E Wong","year":"2017","unstructured":"Wong E, Mahmood MN, Salopek TG (2017) Concomitant B hairy cell leukemia and mycosis fungoides in an elderly man. Case Rep Dermatol 9(1):103\u2013107","journal-title":"Case Rep Dermatol"},{"issue":"2","key":"4349_CR59","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2133.2006.07346.x","volume":"2155","author":"A Barzilai","year":"2006","unstructured":"Barzilai A, Trau H, David M, Feinmesser M, Bergman R, Shpiro D, Schiby G, Rosenblatt K, Or R, Hodak E (2006) Mycosis fungoides associated with B-cell malignancies. Br J Dermatol 2155(2):379\u2013386","journal-title":"Br J Dermatol"},{"issue":"10","key":"4349_CR60","first-page":"E27","volume":"86","author":"GG Wulf","year":"2001","unstructured":"Wulf GG, Schulz H, Hallermann C, Kunze E, W\u00f6rmann B (2001) Reactive polyclonal T-cell lymphocytosis mimicking Sezary syndrome in a patient with hairy cell leukemia. Haematologica. 86(10):E27","journal-title":"Haematologica."},{"key":"4349_CR61","first-page":"1736854","volume":"2018","author":"A Prakash","year":"2018","unstructured":"Prakash A, Khalafallah AA (2018) Concurrent hairy cell leukemia and metastatic merkel cell carcinoma. Case Rep Oncol Med 2018:1736854","journal-title":"Case Rep Oncol Med"},{"issue":"1","key":"4349_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1\u201311","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4349_CR63","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0049-0172(96)80044-8","volume":"26","author":"MD Wooten","year":"1996","unstructured":"Wooten MD, Jasin HE (1996) Vasculitis and lymphoproliferative diseases. Semin Arthritis Rheum 26(2):564\u2013574","journal-title":"Semin Arthritis Rheum"},{"key":"4349_CR64","doi-asserted-by":"crossref","first-page":"bcr2012007123","DOI":"10.1136\/bcr-2012-007123","volume":"2012","author":"S Gulati","year":"2012","unstructured":"Gulati S, Patel NP, Swierczynski SL (2012) Vasculitides associated with haematological malignancies: a case-based review. BMJ Case Rep 2012:bcr2012007123","journal-title":"BMJ Case Rep"},{"issue":"8","key":"4349_CR65","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/art.23085","volume":"57","author":"O Fain","year":"2007","unstructured":"Fain O, Hamidou M, Cacoub P, Godeau B, Wechsler B, Pari\u00e8s J, Stirnemann J, Morin AS, Gatfosse M, Hanslik T, Belmatoug N, Bl\u00e9try O, Cevallos R, Delevaux I, Fisher E, Hayem G, Kaplan G, Le Hello C, Mouthon L, Larroche C, Lemaire V, Piette AM, Piette JC, Ponge T, Puechal X, Rossert J, Sarrot-Reynauld F, Sicard D, Ziza JM, Kahn MF, Guillevin L (2007) Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum 57(8):1473\u20131480","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4349_CR66","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2257.2000.00283.x","volume":"22","author":"MR Grey","year":"2000","unstructured":"Grey MR, Flanagan NG, Kelsey PR (2000) Severe skin rash in two consecutive patients treated with 2-chlorodeoxyadenosine for hairy cell leukaemia at a single institution. Clin Lab Haematol 22(2):111\u2013113","journal-title":"Clin Lab Haematol"},{"key":"4349_CR67","doi-asserted-by":"publisher","unstructured":"Broccoli A, Gandolfi L, Pellegrini C, Agostinelli C, Argnani L, Zinzani PL (2016) Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: a case report and review of the literature. Tumori 102(Suppl. 2). https:\/\/doi.org\/10.5301\/tj.5000487","DOI":"10.5301\/tj.5000487"},{"issue":"6","key":"4349_CR68","first-page":"1167","volume":"13","author":"SE Gabriel","year":"1986","unstructured":"Gabriel SE, Conn DL, Phyliky RL, Scott RE (1986) Vasculitis in hairy cell leukaemia: review of literature and consideration of possible pathogenic mechanisms. J Rheumatol 13(6):1167\u20131172","journal-title":"J Rheumatol"},{"issue":"2","key":"4349_CR69","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0049-0172(95)80026-3","volume":"25","author":"P Hasler","year":"1995","unstructured":"Hasler P, Kistler H, Gerber H (1995) Vasculitides in hairy cell leukemia. Semin Arthritis Rheum 25(2):134\u2013142","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"4349_CR70","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejim.2006.09.032","volume":"18","author":"A Remkova","year":"2007","unstructured":"Remkova A, Halc\u00edn A, Stenov\u00e1 E, Bab\u00e1l P, Kasperov\u00e1 V, Vranovsk\u00fd A (2007) Acute vasculitis as a first manifestation of hairy cell leukemia. Eur J Intern Med 18(3):238\u2013240","journal-title":"Eur J Intern Med"},{"issue":"3","key":"4349_CR71","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.lpm.2013.07.022","volume":"43","author":"A Audemard","year":"2014","unstructured":"Audemard A, Crochette R, Sala\u00fcn V, Comoz F, Ficheux M (2014) IgA vasculitis revealing hairy cell leukemia relapse treated by cladribine. Presse Med 43(3):321\u2013323","journal-title":"Presse Med"},{"issue":"12","key":"4349_CR72","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/ajh.25597","volume":"94","author":"JT Moyers","year":"2019","unstructured":"Moyers JT, Liu LW, Ossowski S, Goddard L, Kamal MO, Cao H (2019) A rash in a hairy situation: leukocytoclastic vasculitis at presentation of hairy cell leukemia. Am J Hematol 94(12):1433\u20131434","journal-title":"Am J Hematol"},{"issue":"4","key":"4349_CR73","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archinte.1987.00370040042008","volume":"147","author":"JP Farcet","year":"1987","unstructured":"Farcet JP, Weschsler J, Wirquin V, Divine M, Reyes F (1987) Vasculitis in hairy cell leukemia. Arch Intern Med 147(4):660\u2013664","journal-title":"Arch Intern Med"},{"issue":"2","key":"4349_CR74","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2141.1985.tb02835.x","volume":"61","author":"CA Westbrook","year":"1985","unstructured":"Westbrook CA, Golde DW (1985) Autoimmune disease in hairy cell leukaemia: clinical syndromes and treatment. Br J Haematol 61(2):349\u2013356","journal-title":"Br J Haematol"},{"issue":"4","key":"4349_CR75","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1365-2257.2002.00453.x","volume":"24","author":"B Tousi","year":"2002","unstructured":"Tousi B, D\u2019Silva R, Papish S (2002) Systemic vasculitis complicating hairy cell leukaemia treatment with cladribine. Clin Lab Haematol 24(4):259\u2013260","journal-title":"Clin Lab Haematol"},{"issue":"9","key":"4349_CR76","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0145-2126(00)00067-9","volume":"24","author":"P Seshadri","year":"2000","unstructured":"Seshadri P, Hadges S, Cropper T (2000) Acute necrotising vasculitis in hairy cell leukemia\u2014rapid response to cladribine: case report and a brief review of the literature. Leuk Res 24(9):791\u2013793","journal-title":"Leuk Res"},{"issue":"8697","key":"4349_CR77","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s disease (1990) Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet 335(8697):1078\u20131080","journal-title":"Lancet"},{"issue":"3","key":"4349_CR78","first-page":"323","volume":"96","author":"TH Oo","year":"2003","unstructured":"Oo TH, Delafuente M, Hassoun H (2003) Possible association between hairy cell leukemia and Beh\u00e7et\u2019s disease. South Med J 96(3):323\u2013324","journal-title":"South Med J"},{"issue":"6","key":"4349_CR79","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/1756-185X.12370","volume":"17","author":"MF Oksuz","year":"2014","unstructured":"Oksuz MF, Coskun BN, Tufan AN, Orucoglu N, Dalkilic E, Ozt\u00fcrk Nazl\u0131o\u011flu H, Pehlivan Y (2014) Hairy cell leukemia presenting initially with symptoms of Beh\u00e7et\u2019s disease. Int J Rheum Dis 17(6):689\u2013692","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"4349_CR80","first-page":"349","volume":"9","author":"AJ Weinstein","year":"1982","unstructured":"Weinstein AJ (1982) Systemic vasculitis and hairy cell leukemia. J Rheumatol 9(3):349\u2013350","journal-title":"J Rheumatol"},{"issue":"6","key":"4349_CR81","first-page":"1150","volume":"21","author":"MT Carpenter","year":"1994","unstructured":"Carpenter MT, West SG (1994) Polyarteritis nodosa in hairy cell leukemia: treatment with interferon-alpha. J Rheumatol 21(6):1150\u20131152","journal-title":"J Rheumatol"},{"issue":"21","key":"4349_CR82","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2169\/internalmedicine.50.6241","volume":"50","author":"A Ozkok","year":"2011","unstructured":"Ozkok A, Elcioglu OC, Akpinar TS, Nalcaci M (2011) Vasculitis in a patient with hairy cell leukemia. Intern Med 50(21):2713","journal-title":"Intern Med"},{"issue":"10","key":"4349_CR83","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/jcp.2006.045385","volume":"60","author":"M Vankalakunti","year":"2007","unstructured":"Vankalakunti M, Joshi K, Jain S, Nada R, Radotra BD, Varma S (2007) Polyarteritis nodosa in hairy cell leukaemia: an autopsy report. J Clin Pathol 60(10):1181\u20131182","journal-title":"J Clin Pathol"},{"issue":"4","key":"4349_CR84","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0049-0172(89)90046-2","volume":"18","author":"KH Komadina","year":"1989","unstructured":"Komadina KH, Houk RW (1989) Polyarteritis nodosa presenting as recurrent pneumonia following splenectomy for hairy-cell leukemia. Semin Arthritis Rheum 18(4):252\u2013257","journal-title":"Semin Arthritis Rheum"},{"key":"4349_CR85","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3389\/fimmu.2019.00414","volume":"10","author":"MS Heath","year":"2019","unstructured":"Heath MS, Ortega-Loayza A (2019) Insights into the pathogenesis of Sweet\u2019s syndrome. Front Immunol 10:414","journal-title":"Front Immunol"},{"issue":"2","key":"4349_CR86","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5070\/D3218502GG","volume":"15","author":"F Ventura","year":"2009","unstructured":"Ventura F, Rocha J, Pereira T, Marques H, Pardal F, Brito C (2009) Sweet syndrome as the presenting symptom of hairy cell leukemia. Dermatol Online J 15(2):12","journal-title":"Dermatol Online J"},{"issue":"12","key":"4349_CR87","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/archderm.138.12.1551","volume":"138","author":"RM Levy","year":"2002","unstructured":"Levy RM, Junkins-Hopkins JM, Turchi JJ, James WD (2002) Sweet syndrome as the presenting symptom of relapsed hairy cell leukemia. Arch Dermatol 138(12):1551\u20131554","journal-title":"Arch Dermatol"},{"issue":"5","key":"4349_CR88","first-page":"765","volume":"67","author":"P Dalr\u00ec","year":"1982","unstructured":"Dalr\u00ec P, Boi S, Cristofolini M, Piscioli F, Rubertelli M (1982) Sweet syndrome: presenting symptom of hairy cell leukemia with fatal infection by Pneumocystis carinii. Haematologica. 67(5):765\u2013768","journal-title":"Haematologica."},{"key":"4349_CR89","doi-asserted-by":"crossref","first-page":"823286","DOI":"10.1155\/2014\/823286","volume":"2014","author":"M Alkayem","year":"2014","unstructured":"Alkayem M, Cheng W (2014) A case report of hairy cell leukemia presenting concomitantly with sweet syndrome. Case Rep Med 2014:823286","journal-title":"Case Rep Med"},{"issue":"3","key":"4349_CR90","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00000372-198306000-00016","volume":"5","author":"SD Gisser","year":"1983","unstructured":"Gisser SD (1983) Acute febrile neutrophilic dermatosis (Sweet\u2019s syndrome) in a patient with hairy-cell leukemia. Am J Dermatopathol 5(3):283\u2013288","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"4349_CR91","volume":"180","author":"PR Shah","year":"2019","unstructured":"Shah PR, Scott G, Beck LA (2019) Image gallery: hairy-cell leukaemia presenting with Sweet syndrome. Br J Dermatol 180(1):e3","journal-title":"Br J Dermatol"},{"issue":"3","key":"4349_CR92","first-page":"270","volume":"34","author":"H \u00d6zdo\u011fu","year":"2017","unstructured":"\u00d6zdo\u011fu H, Yeral M, Bo\u011fa C (2017) An unusual giant leg ulcer as a rare presentation of Sweet\u2019s syndrome in a patient with hairy cell leukemia successfully managed by splenectomy. Turk J Haematol 34(3):270\u2013271","journal-title":"Turk J Haematol"},{"issue":"10","key":"4349_CR93","first-page":"176","volume":"117","author":"C Kromer","year":"2020","unstructured":"Kromer C, Sch\u00f6n MP, Buhl T (2020) Sweet\u2019s syndrome as precursor of hairy cell leukemia. Dtsch Arztebl Int 117(10):176","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"4349_CR94","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7861\/clinmedicine.19-3-224","volume":"19","author":"C George","year":"2019","unstructured":"George C, Deroide F, Rustin M (2019) (1019) Pyoderma gangrenosum - a guide to diagnosis and management. Clin Med (Lond) 19(3):224\u2013228","journal-title":"Clin Med (Lond)"},{"issue":"3","key":"4349_CR95","doi-asserted-by":"crossref","first-page":"e13412","DOI":"10.1111\/dth.13412","volume":"33","author":"A Janowska","year":"2020","unstructured":"Janowska A, Oranges T, Fissi A, Davini G, Romanelli M, Dini V (2020) PG-TIME: a practical approach to the clinical management of pyoderma gangrenosum. Dermatol Ther 33(3):e13412","journal-title":"Dermatol Ther"},{"issue":"9","key":"4349_CR96","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1524-4725.1987.tb00581.x","volume":"13","author":"RP Kaplan","year":"1987","unstructured":"Kaplan RP, Newman G, Saperia D (1987) Pyoderma gangrenosum and hairy cell leukemia. J Dermatol Surg Oncol 13(9):1029\u20131031","journal-title":"J Dermatol Surg Oncol"},{"issue":"2","key":"4349_CR97","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12288-016-0713-8","volume":"33","author":"A Jain","year":"2017","unstructured":"Jain A, Lad D, Prakash G, Khadwal A, Malhotra P, Bal A, Mallik N, Kumar N, Varma S (2017) Bullous pyoderma gangrenosum associated with hairy cell leukemia and its complete response to cladribine therapy. Indian J Hematol Blood Transfus 33(2):273\u2013275","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"5","key":"4349_CR98","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3904\/kjim.2015.30.5.739","volume":"30","author":"A Tombak","year":"2015","unstructured":"Tombak A, Aygun S, Serinsoz E, Tiftik EN (2015) Complete recovery of pyoderma gangrenosum after successful treatment of underlying hairy cell leukemia with cladribine. Korean J Intern Med 30(5):739\u2013741","journal-title":"Korean J Intern Med"},{"issue":"1","key":"4349_CR99","first-page":"83","volume":"109","author":"D Svecov\u00e1","year":"2018","unstructured":"Svecov\u00e1 D, Pallov\u00e1 A, Chmurov\u00e1 N, Babal P (2018) Paraneoplastic vasculitis associated with hairy cell leukemia. Prague Med Rep 109(1):83\u201387","journal-title":"Prague Med Rep"},{"issue":"5 Pt 1","key":"4349_CR100","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0190-9622(84)80454-5","volume":"11","author":"MC Finan","year":"1984","unstructured":"Finan MC, Su WP, Li CY (1984) Cutaneous findings in HCL. J Am Acad Dermatol 11(5 Pt 1):788\u2013797","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"4349_CR101","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.leukres.2011.01.006","volume":"35","author":"RJ Filho","year":"2011","unstructured":"Filho RJ, de Carvalho PN, Neto AM, Teixeira Henderson MN, Pinheiro RF (2011) Nontuberculous mycobacterium genital infection mimicking donovanosis in a patient with hairy cell leukemia. Leuk Res 35(5):e44\u2013e45","journal-title":"Leuk Res"},{"issue":"2","key":"4349_CR102","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/1097-0142(19810715)48:2<380::AID-CNCR2820480226>3.0.CO;2-N","volume":"48","author":"RA Weinstein","year":"1981","unstructured":"Weinstein RA, Golomb HM, Grumet G, Gelmann E, Schechter GP (1981) Hairy cell leukemia: association with disseminated atypical mycobacterial infection. Cancer 48(2):380\u2013383","journal-title":"Cancer"},{"issue":"3","key":"4349_CR103","first-page":"241","volume":"67","author":"Z Trizna","year":"2001","unstructured":"Trizna Z, Tschen J, Natelson EA (2001) Atypical mycobacterial infection in a patient with hairy cell leukemia. Cutis. 67(3):241\u2013242","journal-title":"Cutis."},{"issue":"2","key":"4349_CR104","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF01982188","volume":"13","author":"B Castor","year":"1994","unstructured":"Castor B, Juhlin I, Henriques B (1994) Septic cutaneous lesions caused by Mycobacterium malmoense in a patient with hairy cell leukemia. Eur J Clin Microbiol Infect Dis 13(2):145\u2013148","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"4349_CR105","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/archderm.1988.01670100047012","volume":"124","author":"PD Maurice","year":"1988","unstructured":"Maurice PD, Bunker C, Giles F, Goldstone A, Holton J (1988) Mycobacterium avium-intracellular infection associated with hairy-cell leukemia. Arch Dermatol 124(10):1545\u20131549","journal-title":"Arch Dermatol"},{"issue":"2","key":"4349_CR106","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/ajh.2830460214","volume":"46","author":"S Kumar","year":"1994","unstructured":"Kumar S, Kumar D, Gourley WK, Alperin JB (1994) Sporotrichosis as a presenting manifestation of hairy cell leukemia. Am J Hematol 46(2):134\u2013137","journal-title":"Am J Hematol"},{"issue":"6","key":"4349_CR107","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/0002-9343(86)90410-9","volume":"81","author":"RA Salata","year":"1986","unstructured":"Salata RA, King RE, Gose F, Pearson RD (1986) Listeria monocytogenes cerebritis, bacteremia, and cutaneous lesions complicating hairy cell leukemia. Am J Med 81(6):1068\u20131072","journal-title":"Am J Med"},{"key":"4349_CR108","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1179\/acb.2008.081","volume":"63","author":"S Bettens","year":"2008","unstructured":"Bettens S, Delaere B, Glupczynski Y, Schoevaerdts D, Swine C (2008) Ecthyma gangrenosum in a non-neutropaenic, elderly patient: case report and review of the literature. Acta Clin Belg 63:394\u2013397","journal-title":"Acta Clin Belg"},{"issue":"1","key":"4349_CR109","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12879-018-3644-1","volume":"19","author":"R Sluga","year":"2019","unstructured":"Sluga R, Tersmette M, Sohne M (2019) Hairy cell leukemia presenting with Ecthyma Gangrenosum- a case report. BMC Infect Dis 19(1):85","journal-title":"BMC Infect Dis"},{"issue":"6","key":"4349_CR110","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3109\/10428194.2011.635864","volume":"53","author":"C Ganzel","year":"2012","unstructured":"Ganzel C, Gatt ME, Maly A, Ben-Yehuda D, Goldschmidt N (2012) High incidence of skin rash in patients with hairy cell leukemia treated with cladribine. Leuk Lymphoma 53(6):1169\u20131173","journal-title":"Leuk Lymphoma"},{"issue":"14","key":"4349_CR111","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1080\/10428194.2019.1633640","volume":"60","author":"Z Meher-Homji","year":"2019","unstructured":"Meher-Homji Z, Tam CS, Siderov J, Seymour JF, Holmes NE, Chua KYL, Phillips EJ, Slavin MA, Trubiano JA (2019) High prevalence of antibiotic allergies in cladribine-treated patients with hairy cell leukemia - lessons for immunopathogenesis and prescribing. Leuk Lymphoma 60(14):3455\u20133460","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"4349_CR112","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00000372-199902000-00085","volume":"21","author":"PR Cohen","year":"1999","unstructured":"Cohen PR, Kurzrock R (1999) 2-chloro-deoxyadenosine-associated transient acantholytic dermatosis in hairy cell leukemia patients. Am J Dermatopathol 21(1):106\u2013108","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"4349_CR113","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.2003.04506.x","volume":"122","author":"Y Chubar","year":"2003","unstructured":"Chubar Y, Bennett M (2003) Cutaneous reactions in hairy cell leukaemia treated with 2-chlorodeoxyadenosine and allopurinol. Br J Haematol 122(5):768\u2013770","journal-title":"Br J Haematol"},{"issue":"7","key":"4349_CR114","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00277-017-2992-z","volume":"96","author":"P Espinosa Lara","year":"2017","unstructured":"Espinosa Lara P, Quir\u00f3s Redondo V, Aguado Lobo M, Jim\u00e9nez-Reyes J (2017) Purpuric exanthema in a patient with hairy cell leukemia treated with cladribine and allopurinol. Ann Hematol 96(7):1209\u20131210","journal-title":"Ann Hematol"},{"issue":"20","key":"4349_CR115","first-page":"30600","volume":"S2213-2198","author":"J Castagna","year":"2020","unstructured":"Castagna J, Amsler E, Kurihara F, Chasset F, Barbaud A, Soria A (2020) Atypical features of cutaneous adverse drug reactions during therapy for hairy cell leukemia. J Allergy Clin Immunol Pract S2213-2198(20):30600\u201330600","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"4349_CR116","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/1096-8652(199611)53:3<209::AID-AJH2830530303>3.0.CO;2-L","volume":"53","author":"S Zevin","year":"1996","unstructured":"Zevin S, Hershko C, Rosenmann E (1996) Halogenoderma of the forearm caused by 2-chlorodeoxyadenosine treatment. Am J Hematol 53(3):209\u2013210","journal-title":"Am J Hematol"},{"issue":"7","key":"4349_CR117","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1177\/0300060519856158","volume":"47","author":"C Li","year":"2019","unstructured":"Li C, Geng H, Ji L, Jiang Y, Ma X, Yin Q, Xiong H (2019) Severe polymorphic erythema due to interferon \u03b1-2b during treatment of hairy cell leukemia. J Int Med Res 47(7):3453\u20133457","journal-title":"J Int Med Res"},{"issue":"4","key":"4349_CR118","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/1346-8138.12389","volume":"41","author":"M Urosevic-Maiwald","year":"2014","unstructured":"Urosevic-Maiwald M, Nobbe S, Kerl K, Benz R (2014) Disseminated ulcerating lupus panniculitis emerging under interferon therapy of hairy cell leukemia: treatment- or disease-related? J Dermatol 41(4):329\u2013333","journal-title":"J Dermatol"},{"issue":"10","key":"4349_CR119","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/jamadermatol.2015.1745","volume":"151","author":"G Carlos","year":"2015","unstructured":"Carlos G, Anforth R, Clements A, Menzies AM, Carlino MS, Chou S, Fernandez-Pe\u00f1as P (2015) Cutaneous toxic effects of BRAF inhibitors alone and in combination with MEK inhibitors for metastatic melanoma. JAMA Dermatol 151(10):1103\u20131109","journal-title":"JAMA Dermatol"},{"issue":"S2","key":"4349_CR120","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/hon.72_2629","volume":"37","author":"E Tiacci","year":"2019","unstructured":"Tiacci E, De Carolis L, Simonetti E, Zaja F, Capponi M, Ambrosetti A, Lucia E, Antolino A, Pulsoni A, Ferrari S, Zinzani P, Rigacci L, Gaidano G, Della Seta R, Frattarelli N, Falcucci P, Visani G, Foa R, Falini B (2019) The BRAF inhibitor vemurafenib plus rituximab produces a high rate of deep and durable responses in relapsed\/refractory hairy cell leukemia: updated results of a phase-2 trial. Hematol Oncol 37(S2):110\u2013111","journal-title":"Hematol Oncol"},{"key":"4349_CR121","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/ddg.14202","volume":"18","author":"F Bellinato","year":"2020","unstructured":"Bellinato F, Maurelli M, Gisondi P, Girolomoni G (2020) Clinical features and treatments of transient acantholytic dermatosis (Grover\u2019s disease): a systematic review. J Dtsch Dermatol Ges 18:826\u2013833. https:\/\/doi.org\/10.1111\/ddg.14202","journal-title":"J Dtsch Dermatol Ges"},{"issue":"2","key":"4349_CR122","doi-asserted-by":"crossref","first-page":"13030\/qt3ps3356","DOI":"10.5070\/D3262047420","volume":"26","author":"AG Singh","year":"2020","unstructured":"Singh AG, Tchanque-Fossuo CN, Elwood H, Durkin JR (2020) BRAF inhibitor and hairy cell leukemia-related transient acantholytic dermatosis. Dermatol Online J 26(2):13030\/qt3ps33564","journal-title":"Dermatol Online J"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04349-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-020-04349-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04349-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T23:03:55Z","timestamp":1697151835000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-020-04349-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":122,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["4349"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04349-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,20]]},"assertion":[{"value":"26 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}